DJS Antibodies

DJS Antibodies is a startup based in the United Kingdom. DJS Antibodies has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.

DJS Antibodies was a biotechnology company based in Oxford, UK, specializing in the discovery and development of antibody-based therapeutics. They focused on targeting G protein-coupled receptors (GPCRs) for autoimmune and inflammatory diseases, and were acquired by AbbVie in 2022.